Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, M.R.C.P (UK), M.D (US)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Pulmonologist
M.B.B.S., MD I Medicine , MCPS ( Pulmonology )
Endocrinologist
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Endocrinologist
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Rheumatologist
MBBS, FCPS (Medicine), FCPS ( Rheumatology), CHPE , FRCP, CHPE
Rheumatologist
MBBS, FCPS (Medicine), FCPS ( Rheumatology), CHPE , FRCP, CHPE
Internal Medicine Specialist
M.B.B.S, M.D (USA), M.C.P.S, M.R.C.G.P
Rheumatologist
MBBS, FCPS (Medicine), FCPS (Rheumatology)
Endocrinologist
MBBS, MRCS, PGD in Endocrinology (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, Internal Medicine, DABIM, M.D
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures